Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-16T18:39:35.010Z Has data issue: false hasContentIssue false

Study of Cerebrospinal Fluid Shunt–Associated Infections in the First Year Following Placement, by the Canadian Nosocomial Infection Surveillance Program

Published online by Cambridge University Press:  02 January 2015

Joanne M. Langley*
Affiliation:
Departments of Pediatrics and Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia Canadian Center for Vaccinology, IWK Health Centre, Halifax, Nova Scotia
Denise Gravel
Affiliation:
Center for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario
Dorothy Moore
Affiliation:
Montreal Children's Hospital, Montreal, Quebec, Canada
Anne Matlow
Affiliation:
Hospital for Sick Children, Toronto, Ontario
Joanne Embree
Affiliation:
Winnipeg Health Sciences Centre, Winnipeg, Manitoba, Canada
Donna MacKinnon-Cameron
Affiliation:
Canadian Center for Vaccinology, IWK Health Centre, Halifax, Nova Scotia
John Conly
Affiliation:
University of Calgary, Calgary, Alberta, Canada
*
IWK Health Centre, 5850 University Avenue, PO Box 9700, Halifax, Nova Scotia, CanadaB3K 6R8 (joanne.langley@dal.ca)

Abstract

In a national surveillance system study, the infection rate following cerebrospinal fluid shunt surgery was 4.1% (95% confidence interval, 3.36%-4.92%). Cases of infection were more common in children than in adults (4.85% vs 3.24%; P = .04) and occurred sooner after surgery in children than in adults. A wide variation in compliance with antimicrobial prophylaxis was observed between 21 participating medical centers.

Type
Concise Communications
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Patwardhan, RV, Nanda, A. Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005;56:139144.Google Scholar
2.Schoenbaum, SC, Gardner, P, Shillito, J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 1975;131:543552.Google Scholar
3.McLone, D, Czyzewski, D, Raimondi, A, Sommers, R. Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocoele. Pediatrics 1982;70:338342.Google Scholar
4.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470485.CrossRefGoogle Scholar
5.Horan, TC, Gaynes, RP, Martone, WJ, Jarvis, WR, Emori, TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606608.Google Scholar
6.Thompson, DN, Hartley, JC, Hayward, RD. Shunt infection: is there a near-miss scenario? J Neurosurg 2007;106(1 Suppl):1519.Google Scholar
7.Choux, M, Genitori, L, Lang, D, Lena, G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992;77:875880.Google Scholar
8.Mottolese, C, Grando, J, Convert, J, et al.Zero rate of shunt infection in the first postoperative year in children—dream or reality? Childs Nerv Syst 2000;16:210212.Google Scholar
9.Ratilai, B, Costa, J, Sampaio, C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a. systematic review. J Neurosurg Pediatrics 2008;1:4856.Google Scholar
10.Bratzier, DW, Houck, PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005;189:395404.CrossRefGoogle Scholar